Oyster Point Pharma (OYST)
NASDAQ:OYST
US Market
Holding OYST?
Track your performance easily

Oyster Point Pharma (OYST) Financial Statements

0 Followers

Oyster Point Pharma Financial Overview

Oyster Point Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Oyster Point Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 5.59M$ 4.69M$ 2.70M$ 6.60M$ 17.94M
Gross Profit$ 4.24M$ 3.38M$ 2.37M$ 5.07M-
EBIT$ -33.25M$ -46.79M$ -44.83M$ -39.45M$ -16.55M
EBITDA$ -33.18M$ -46.67M$ -44.75M$ -39.40M$ -16.51M
Net Income Common Stockholders$ -36.75M$ -49.94M$ -47.89M$ -42.06M$ -17.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 68.80M$ 104.88M$ 143.36M$ 193.37M$ 184.17M
Total Assets$ 109.20M$ 143.94M$ 176.72M$ 222.62M$ 195.01M
Total Debt$ 94.72M$ 94.14M$ 93.36M$ 92.73M$ 42.58M
Net Debt$ 25.92M$ -10.73M$ -50.01M$ -100.64M$ -141.59M
Total Liabilities$ 131.40M$ 133.16M$ 120.73M$ 123.08M$ 57.50M
Stockholders Equity$ -22.20M$ 10.78M$ 55.99M$ 99.54M$ 137.51M
Cash Flow-
Free Cash Flow$ -35.97M$ -38.95M$ -49.79M$ -41.71M$ -11.07M
Operating Cash Flow$ -35.97M$ -38.83M$ -49.70M$ -41.48M$ -10.81M
Investing Cash Flow$ 0.00$ -118.00K$ -85.00K$ -235.00K$ -256.00K
Financing Cash Flow$ -166.00K$ 460.00K$ -218.00K$ 50.92M$ 40.43M
Currency in USD

Oyster Point Pharma Earnings and Revenue History

Oyster Point Pharma Debt to Assets

Oyster Point Pharma Cash Flow

Oyster Point Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis